Providing the most advanced and appropriate care for each cancer patient is a priority at MD Anderson, as demonstrated in the following stories.
In 2004, James Yao, M.D., learned that one patient can open a whole new world of possibilities. After examining a young woman with two rare diseases, he asked himself: "Are there similarities in the two that might present a treatment target?" That was the beginning of the quest that led him to everolimus.
When Joseph Nates, M.D., joined MD Anderson's faculty in 2002, he discovered a high incidence of ventilator-associated pneumonia. By 2009, he and his team had brought its occurrence to zero.
As he ends each week traveling from Katy to the Bay Area to care for his patients, Richard Ehlers, M.D., never loses sight of his calling. Ehlers is part of a growing team of highly trained MD Anderson surgical oncologists who care for patients through the institution's ever-expanding suburban regional care network.
Reginald Munden, M.D., sees a light at the end of the tunnel with the release of the findings of the National Lung Screening Trial. The bright glimmer is that the trial reported a 20% reduction in lung cancer deaths among trial participants — heavy smokers — whose lung cancers were first spotted with a low-dose helical CT scan.
The mirror is not always a glowing reflection of one's self. For Jason Cox, there was a point when he didn't even recognize himself. Today, though, his reflection shows a successful attorney, a community volunteer and, most important, a survivor.
MD Anderson's growing cancer survivorship program includes seed grants to support research, a website and nine survivorship clinics.